李汉兵 - 浙江工业大学

研究领域

科研上主要研究方向包括药物筛选与评价、糖尿病等胰岛素抵抗性疾病的机理研究、生物相容性材料研究与开发。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Li HB, Yang YR, Mo ZJ, Ding Y, Jiang WJ. Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition. Braz J Med Biol Res. 2015;48(5):440-6. 2. Hanbing Li, Yunxue Pan, Jing Nie. Astragaloside IV improved insulin resistance in L6 myotubes induced by high glucose and insulin. Inernational Conference on Remote Sensing, Enviroment and Transportantion Engineering (RSETE), 2011,7515-7518. 3. Han-Bing Li, Ya-Kun Ge, Xiao-Xiang Zheng, Le Zhang. Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase. European Journal of Pharmacology 2008,588:165-169 (IF:2.447) 4. Han-Bing Li, Ya-Kun Ge, Le Zhang, Xiao-Xiang Zheng. Astragaloside IV improved endothelial barrier dysfunction in vitro induced by hyperglycemia. Life Sciences 2006,79:1186-1193 (IF:2.389) 5. Han-Bing Li, Tong-Le Deng, Qing-Nan Zhang, Xiao-Xiang Zheng. Label-free and Dynamic Monitoring of Endothelial Barrier Function on Microelectronic Cell Sensor Arrays. Chinese Journal of Cell Biology 2007,29:91-96 6. Xiaoxiang Zheng, Yun Zhang, Wei Yuan, Xiaolong Li, Hanbing Li, Weimin Yan,　A series of methods For screening and evaluating potential anti-cardiovascular drugs from traditional Chinese herbs, Recent progress in medicinal plants, volume 25(Chemistry and medicinal value), U.S.A. Studium Press LLC, 2009:185-201